期刊
NEUROBIOLOGY OF DISEASE
卷 108, 期 -, 页码 115-127出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2017.08.009
关键词
-
资金
- National Institutes of Health [T32ES007148, P30ES005022, R01ES021800, R01NS088627, R21DE025689, R01NS088267]
- Michael J Fox Foundation for Parkinson's Disease Research
Inflammation arising from central and/or peripheral sources contributes to the pathogenesis of multiple neuro-degenerative diseases including Parkinson's disease (PD). Emerging data suggest that differential activation of glia could lead to the pathogenesis and progression of PD. Here, we sought to determine the relationship between lipopolysaccharide (LPS) treatment, loss of dopaminergic neurons and differential activation of glia. Using a model of repeated injections with LPS (1 mg/kg, i.p. for 4 days), we found that LPS induced a 34% loss of dopamine neurons in the substantia nigra 19 days after initiation of treatment, but no further cell loss was observed at 36 days. LPS induced a strong pro-inflammatory response with increased mRNA expression of pro-inflammatory markers, including tumor necrosis factor-alpha (4.8-fold), inducible nitric oxide synthase (2.0-fold), interleukin-1 beta (8.9-fold), interleukin-6 (10.7-fold), and robust glial activation were observed at 1 day after final dose of LPS. These pro-inflammatory genes were then reduced at 19 days after treatment, when there was a rise in the anti-inflammatory genes Ym1 (1.8-fold) and arginase-1 (2.6-fold). Additionally, 36 days after the last LPS injection there was a significant increase in interleukin-10 (2.1-fold) expression. The qPCR data results were supported by protein data, including cytokine measurements, western blotting, and immunofluorescence in brain microglia. Taken together, these data demonstrate that progressive neurodegeneration in the substantia nigra following LPS is likely arrested by microglia shifting to an anti-inflammatory phenotype. Thus, strategies to promote resolution of neuroinflammation may be a promising avenue to slow the progressive loss of dopamine neurons in PD. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据